These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 26287338

  • 1. [Glucocorticoid combined with ulinastatin in treatment of Kawasaki disease in children: a non-randomized controlled clinical trial].
    Zhao DM, Yin QL, Ji XH, Haiweier M, Meng GY, Cheng QT, Ju LJ.
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Aug; 17(8):780-5. PubMed ID: 26287338
    [Abstract] [Full Text] [Related]

  • 2. Ulinastatin therapy in kawasaki disease.
    Iwashima S, Seguchi M, Matubayashi T, Ohzeki T.
    Clin Drug Investig; 2007 Aug; 27(10):691-6. PubMed ID: 17803344
    [Abstract] [Full Text] [Related]

  • 3. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
    Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, Wu R, Shi H.
    Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742
    [Abstract] [Full Text] [Related]

  • 4. Intravenous Immunoglobulin Gamma (IVIG) versus IVIG Plus Infliximab in Young Children with Kawasaki Disease.
    Han CL, Zhao SL.
    Med Sci Monit; 2018 Oct 11; 24():7264-7270. PubMed ID: 30307902
    [Abstract] [Full Text] [Related]

  • 5. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
    Kuo HC, Lo MH, Hsieh KS, Guo MM, Huang YH.
    PLoS One; 2015 Oct 11; 10(12):e0144603. PubMed ID: 26658843
    [Abstract] [Full Text] [Related]

  • 6. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].
    Qin LJ, Wang HW, Hu XF, Liu QJ, Shi H, Wei YX, Chen QJ, Cheng PX.
    Zhonghua Er Ke Za Zhi; 2006 Dec 11; 44(12):891-5. PubMed ID: 17254453
    [Abstract] [Full Text] [Related]

  • 7. Risk factors for coronary artery lesions in children with Kawasaki disease.
    Duan J, Jiang H, Lu M.
    Arch Argent Pediatr; 2020 Oct 11; 118(5):327-331. PubMed ID: 32924395
    [Abstract] [Full Text] [Related]

  • 8. [Changes of P-selectin and E-selectin in children with Kawasaki disease].
    Qiu Y, Wu J, Fang XY, Lin Z, Wu BY, Cai RY, Xu XY, Zheng H.
    Zhonghua Er Ke Za Zhi; 2004 Sep 11; 42(9):688-92. PubMed ID: 15482673
    [Abstract] [Full Text] [Related]

  • 9. TNF-α is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with Kawasaki disease.
    Hu P, Jiang GM, Wu Y, Huang BY, Liu SY, Zhang DD, Xu Y, Wu YF, Xia X, Wei W, Hu B.
    Clin Chim Acta; 2017 Aug 11; 471():76-80. PubMed ID: 28526535
    [Abstract] [Full Text] [Related]

  • 10. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.
    Tremoulet AH, Jain S, Jaggi P, Jimenez-Fernandez S, Pancheri JM, Sun X, Kanegaye JT, Kovalchin JP, Printz BF, Ramilo O, Burns JC.
    Lancet; 2014 May 17; 383(9930):1731-8. PubMed ID: 24572997
    [Abstract] [Full Text] [Related]

  • 11. A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: clinical course and coronary artery outcome.
    Inoue Y, Okada Y, Shinohara M, Kobayashi T, Kobayashi T, Tomomasa T, Takeuchi K, Morikawa A.
    J Pediatr; 2006 Sep 17; 149(3):336-341. PubMed ID: 16939743
    [Abstract] [Full Text] [Related]

  • 12. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
    Xie T, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F.
    Pediatr Rheumatol Online J; 2017 Mar 21; 15(1):17. PubMed ID: 28320400
    [Abstract] [Full Text] [Related]

  • 13. Clinical outcomes of initial dexamethasone treatment combined with a single high dose of intravenous immunoglobulin for primary treatment of Kawasaki disease.
    Lim YJ, Jung JW.
    Yonsei Med J; 2014 Sep 21; 55(5):1260-6. PubMed ID: 25048483
    [Abstract] [Full Text] [Related]

  • 14. [Clinical utility of ulinastatin, urinary protease inhibitor in acute Kawasaki disease].
    Saji T.
    Nihon Rinsho; 2008 Feb 21; 66(2):343-8. PubMed ID: 18265458
    [Abstract] [Full Text] [Related]

  • 15. Relationship between ocular manifestations, laboratory findings, echocardiographic findings, and intravenous immunoglobulin resistance in Kawasaki disease.
    Jari M, Esmaeili H.
    Pediatr Rheumatol Online J; 2024 May 01; 22(1):50. PubMed ID: 38693550
    [Abstract] [Full Text] [Related]

  • 16. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease.
    Newburger JW, Sleeper LA, McCrindle BW, Minich LL, Gersony W, Vetter VL, Atz AM, Li JS, Takahashi M, Baker AL, Colan SD, Mitchell PD, Klein GL, Sundel RP, Pediatric Heart Network Investigators.
    N Engl J Med; 2007 Feb 15; 356(7):663-75. PubMed ID: 17301297
    [Abstract] [Full Text] [Related]

  • 17. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
    Yılmazer MM, Özdemir R, Meşe T, Küçük M, Öner T, Devrim İ, Bayram N, Güven B, Tavlı V.
    Turk J Pediatr; 2019 Feb 15; 61(5):648-656. PubMed ID: 32104995
    [Abstract] [Full Text] [Related]

  • 18. Timing of intravenous immunoglobulin treatment and risk of coronary artery abnormalities in children with Kawasaki disease.
    Bal AK, Prasad D, Umali Pamintuan MA, Mammen-Prasad E, Petrova A.
    Pediatr Neonatol; 2014 Oct 15; 55(5):387-92. PubMed ID: 24636168
    [Abstract] [Full Text] [Related]

  • 19. Do cytokines correlate with refractory Kawasaki disease in children?
    Wang Y, Qian SY, Yuan Y, Wang Q, Gao L, Chen X, Yu X, Zhen Z.
    Clin Chim Acta; 2020 Jul 15; 506():222-227. PubMed ID: 32156603
    [Abstract] [Full Text] [Related]

  • 20. Evolution of laboratory values in patients with Kawasaki disease.
    Tremoulet AH, Jain S, Chandrasekar D, Sun X, Sato Y, Burns JC.
    Pediatr Infect Dis J; 2011 Dec 15; 30(12):1022-6. PubMed ID: 21817952
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.